This content is machine translated Essential thrombocythemia Risk assessment is of vital importance – a look at the data situation Essential thrombocythemia usually occurs after the age of 50, although there are also those affected under the age of 40. Various subtypes can be distinguished based on molecular genetic analyses.…
View Post 3 min This content is machine translated Type 1 diabetes Baricitinib helps beta cells Baricitinib, a JAK1 and JAK2 inhibitor, is often used to treat rheumatoid arthritis, alopecia areata or severe coronavirus disease. Doctors in Australia have also investigated whether the drug could preserve…
View Post 5 min This content is machine translated Rheumatoid arthritis JAK inhibitor reduces pain for a long time Patients with active rheumatoid arthritis often suffer from considerable pain. Therefore, pain control is an important treatment goal in this patient group. In a post-hoc analysis of the FINCH studies…
View Post 7 min This content is machine translated Atopic dermatitis: choice of systemic therapy option “It’s always an individual weighing”. For the treatment of moderate and severe atopic dermatitis, three oral Janus kinase inhibitors are now available in addition to two subcutaneously administered biologics. While the former specifically target individual…
